HappeningToo topic
Insulin Glargine reports
Browse community reports connected to Insulin Glargine. These reports can show that other people are describing similar experiences, but they do not prove that Insulin Glargine caused a symptom or reaction.
⚕️ Medicine safety note
Community reports do not prove causation, cannot be used to estimate how common a reaction is, and are not medical advice.
32 problems
Abdominal Discomfort while using Insulin Glargine
FDA FAERS contains adverse-event reports in which Insulin Glargine and abdominal discomfort appear together. This does not establish that Insulin Glargine caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Abdominal Pain Upper while using Insulin Glargine
FDA FAERS contains adverse-event reports in which Insulin Glargine and abdominal pain upper appear together. This does not establish that Insulin Glargine caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Abdominal Pain while using Insulin Glargine
FDA FAERS contains adverse-event reports in which Insulin Glargine and abdominal pain appear together. This does not establish that Insulin Glargine caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Anxiety while using Insulin Glargine
FDA FAERS contains adverse-event reports in which Insulin Glargine and anxiety appear together. This does not establish that Insulin Glargine caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Back Pain while using Insulin Glargine
FDA FAERS contains adverse-event reports in which Insulin Glargine and back pain appear together. This does not establish that Insulin Glargine caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Constipation while using Insulin Glargine
FDA FAERS contains adverse-event reports in which Insulin Glargine and constipation appear together. This does not establish that Insulin Glargine caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Cough while using Insulin Glargine
FDA FAERS contains adverse-event reports in which Insulin Glargine and cough appear together. This does not establish that Insulin Glargine caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Decreased Appetite while using Insulin Glargine
FDA FAERS contains adverse-event reports in which Insulin Glargine and decreased appetite appear together. This does not establish that Insulin Glargine caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Dehydration while using Insulin Glargine
FDA FAERS contains adverse-event reports in which Insulin Glargine and dehydration appear together. This does not establish that Insulin Glargine caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Diarrhea while using Insulin Glargine
FDA FAERS contains adverse-event reports in which Insulin Glargine and diarrhea appear together. This does not establish that Insulin Glargine caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Dizziness while using Insulin Glargine
FDA FAERS contains adverse-event reports in which Insulin Glargine and dizziness appear together. This does not establish that Insulin Glargine caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Excessive sweating while using Insulin Glargine
FDA FAERS contains adverse-event reports in which Insulin Glargine and excessive sweating appear together. This does not establish that Insulin Glargine caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Fatigue while using Insulin Glargine
FDA FAERS contains adverse-event reports in which Insulin Glargine and fatigue appear together. This does not establish that Insulin Glargine caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Feeling Abnormal while using Insulin Glargine
FDA FAERS contains adverse-event reports in which Insulin Glargine and feeling abnormal appear together. This does not establish that Insulin Glargine caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Headache while using Insulin Glargine
FDA FAERS contains adverse-event reports in which Insulin Glargine and headache appear together. This does not establish that Insulin Glargine caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Hypotension while using Insulin Glargine
FDA FAERS contains adverse-event reports in which Insulin Glargine and hypotension appear together. This does not establish that Insulin Glargine caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Insomnia while using Insulin Glargine
FDA FAERS contains adverse-event reports in which Insulin Glargine and insomnia appear together. This does not establish that Insulin Glargine caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Itching while using Insulin Glargine
FDA FAERS contains adverse-event reports in which Insulin Glargine and itching appear together. This does not establish that Insulin Glargine caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Malaise while using Insulin Glargine
FDA FAERS contains adverse-event reports in which Insulin Glargine and malaise appear together. This does not establish that Insulin Glargine caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Muscle Spasms while using Insulin Glargine
FDA FAERS contains adverse-event reports in which Insulin Glargine and muscle spasms appear together. This does not establish that Insulin Glargine caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Nausea while using Insulin Glargine
FDA FAERS contains adverse-event reports in which Insulin Glargine and nausea appear together. This does not establish that Insulin Glargine caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Pain while using Insulin Glargine
FDA FAERS contains adverse-event reports in which Insulin Glargine and pain appear together. This does not establish that Insulin Glargine caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Peripheral swelling while using Insulin Glargine
FDA FAERS contains adverse-event reports in which Insulin Glargine and peripheral swelling appear together. This does not establish that Insulin Glargine caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Rash while using Insulin Glargine
FDA FAERS contains adverse-event reports in which Insulin Glargine and rash appear together. This does not establish that Insulin Glargine caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Shortness of breath while using Insulin Glargine
FDA FAERS contains adverse-event reports in which Insulin Glargine and shortness of breath appear together. This does not establish that Insulin Glargine caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Sleepiness while using Insulin Glargine
FDA FAERS contains adverse-event reports in which Insulin Glargine and sleepiness appear together. This does not establish that Insulin Glargine caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Tremor while using Insulin Glargine
FDA FAERS contains adverse-event reports in which Insulin Glargine and tremor appear together. This does not establish that Insulin Glargine caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Vision Blurred while using Insulin Glargine
FDA FAERS contains adverse-event reports in which Insulin Glargine and vision blurred appear together. This does not establish that Insulin Glargine caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Vomiting while using Insulin Glargine
FDA FAERS contains adverse-event reports in which Insulin Glargine and vomiting appear together. This does not establish that Insulin Glargine caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Weakness while using Insulin Glargine
FDA FAERS contains adverse-event reports in which Insulin Glargine and weakness appear together. This does not establish that Insulin Glargine caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Weight Decreased while using Insulin Glargine
FDA FAERS contains adverse-event reports in which Insulin Glargine and weight decreased appear together. This does not establish that Insulin Glargine caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Weight Increased while using Insulin Glargine
FDA FAERS contains adverse-event reports in which Insulin Glargine and weight increased appear together. This does not establish that Insulin Glargine caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →